This Biotech Lets Rare-Disease Families Invest In Its Gene Therapy
Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing ...
New Scientist
Next-generation Alzheimer’s drug reduces risk of serious brain bleeds
A new kind of antibody drug that more efficiently enters the brain could slow the progression of Alzheimer's disease with a ...
An experimental Alzheimer’s drug shows promise targeting a different brain protein, new study shows
An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by ...
KRAS-targeting drugs show promise for rare appendix cancer
Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The ...
What a new Alzheimer’s drug could mean for the future of treatment
After years of hits and misses trying to unlock the mysteries of Alzheimer’s disease, experts say recent research has yielded ...
Biogen Shares Fall as Alzheimer’s Tau Trial Data Disappoint
Biogen Inc. shares declined after additional data from a mid-stage study of its Alzheimer’s drug diranersen failed to show ...
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed
By Julie Steenhuysen CHICAGO, July 14 (Reuters) - The lowest dose of Biogen's anti-tau Alzheimer's drug diranersen, which missed its primary goal in a midstage trial, reduced cognitive decline in five ...
The New York Times
World Cup 2026: How Japan made the Round of 32
Japan’s live odds of advancing to the Round of 32 Japan has clinched second in Group F. It will play Brazil in its Round of 32 knockout match in Houston on Monday, June 29. Each square is a specific ...